Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What is the BoD doing today for shareholders ..........

Hopefully the will not be finding buyers for 50%. They should be looking for some entity to buy 49% or less. PTSC should be buying or keeping enough of a percentage to gain controlling interest! Other than this I thought your post was right on!

Or did you mean 50% of the TPL 50%?

Share
New Message
Please login to post a reply